European Journal of Clinical Pharmacology

, Volume 74, Issue 1, pp 139–140 | Cite as

Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

  • Reinier Smit
  • Rob J. van Marum
  • Nathalie C. Péquériaux
  • Daan A. Hollander
  • Michiel W. P. Bleeker
  • Yasamin Latify
  • Walter A. Hermens
  • Hieronymus J. Derijks
Letter to the Editor
First Online:
Received:
Accepted:
  • 113 Downloads
This is a preview of subscription content, log in to check access.

Notes

Author contributions

Reinier Smit: concept and design of manuscript, acquisition of data, analysis and interpretation of data and drafting of the manuscript. Rob J van Marum, Walter A Hermens and Jeroen R Derijks: concept and design of the manuscript, analysis and interpretation of data, drafting of the manuscript and supervision. Yasamin Latify: acquisition of data and administrative support. Nathalie C Péquériaux, Daan A, Michiel WP Bleeker: concept of manuscript acquisition of data and drafting of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Richtlijn antistolling met laagmoleculairgewicht heparines (LMWH) bij nierinsufficiëntie (mei 2012)Google Scholar
  2. 2.
    Hammerstingl C, Omran H (2009) Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures. Thromb Haemost 101:1085–1090PubMedGoogle Scholar
  3. 3.
    Lim W, Dentali F, Eikelboom JW, Crowther MA (2006) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insuffiency. Ann Intern Med 144:673–684CrossRefPubMedGoogle Scholar
  4. 4.
    Nutescu EA, Spinler SA, Wittkowsky A, Dager WE (2009) Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother 43(6):1064–1083CrossRefPubMedGoogle Scholar
  5. 5.
    Atiq F, van den Bemt PM, Leebeek FW, van Gelder T, Versmissen J (2015 Aug) A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency. Eur J Clin Pharmacol 71(8):921–929CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Reinier Smit
    • 1
  • Rob J. van Marum
    • 2
    • 3
  • Nathalie C. Péquériaux
    • 4
  • Daan A. Hollander
    • 5
  • Michiel W. P. Bleeker
    • 6
  • Yasamin Latify
    • 7
  • Walter A. Hermens
    • 1
  • Hieronymus J. Derijks
    • 1
    • 7
  1. 1.ZANOB Pharmacy Jeroen Bosch Hospital‘s-HertogenboschThe Netherlands
  2. 2.Department of General Practice and Elderly Care Medicine VU University Medical CentreAmsterdamThe Netherlands
  3. 3.Department of Geriatrics, Jeroen Bosch Hospital‘s-HertogenboschThe Netherlands
  4. 4.Department of Clinical Chemistry, Jeroen Bosch Hospital‘s-HertogenboschThe Netherlands
  5. 5.Department of Nephrology, Jeroen Bosch Hospital‘s-HertogenboschThe Netherlands
  6. 6.Department of Nephrology, Hospital BernhovenUdenThe Netherlands
  7. 7.Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical PharmacologyUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations